PHK
IMMU

Point72 Hong Kong’s Immunomedics Inc IMMU Stock Holding History

Point72 Hong Kong’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-145
Closed -$2K – 1537
2020
Q1 		$2K Buy
+145
New +$2.44K ﹤0.01% 861
2019
Q4 		– Sell
-10,470
Closed -$139K – 1572
2019
Q3 		$139K Buy
+10,470
New +$154K 0.04% 379
2018
Q3 		– Sell
-152
Closed -$4K – 1314
2018
Q2 		$4K Buy
+152
New +$3.06K ﹤0.01% 735

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Point72 Hong Kong's IMMU Position: Q2 2020 in Review

Point72 Hong Kong sold out of Immunomedics Inc (IMMU) in Q2 2020, closing a stake of 145 shares — an estimated $2K sold.

Point72 Hong Kong first reported a position in IMMU in Q2 2018 and held it in 3 quarters. The position peaked at $139K in Q3 2019. 313 funds tracked by Wall St. Rank hold IMMU as of Q2 2020.

  • Point72 Hong Kong reported no remaining Immunomedics Inc position as of Q2 2020 after selling out during the quarter.
  • Point72 Hong Kong sold 145 Immunomedics Inc shares in Q2 2020, an estimated $2K.
  • Point72 Hong Kong first reported a position in Immunomedics Inc in Q2 2018 and held it in 3 quarters.
  • Point72 Hong Kong's Immunomedics Inc position peaked at $139K in Q3 2019.
  • 313 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2020.

Based on Point72 Hong Kong's 13F filing for Q2 2020, filed 14 Aug 2020.